Effects of glucagon-like peptide-1 receptor agonists on kidney function and safety in type 2 diabetes patients.
Min Kyung KimDoo-Man KimPublished in: Journal of diabetes investigation (2021)
Glucagon-like peptide-1 receptor agonists have been recommended in diabetic kidney disease patients.